Hybrid drug-screening strategy identifies potential SARS-CoV-2 cell-entry inhibitors targeting human transmembrane serine protease

Yufei Feng(Northeast Agricultural University), Wenxin Liu(Jiujiang University), Konda Mani Saravanan(Bharath University), Shuilong Wu(Guangdong Medical College), Xiaoning Cheng(Central People's Hospital of Zhanjiang)
Structural Chemistry
May 11, 2022
Cited by 7


Related Papers